Cabergoline D5
| Product Name | Cabergoline D5 |
|---|---|
| Alternate Names | Cabergoline Stable Isotopes, Stable Isotopes of Cabergoline |
| CAT No. | CS-O-06456 |
| CAS No. | 1426173-20-7 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 456.64 g/mol |
| Mol. For. | C₂₆H₃₂D₅N₅O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Cabergoline |
| Purity | 95% |
| Therapeutic | Anti-Parkinsons |
| Smileys | O=C(N(CCCN(C)C)C(NCC)=O)[C@H]1CN([C@@](C2)([H])[C@@](C1)([H])C3=CC=CC4=C3C2=CN4)C([2H])([2H])/C([2H])=C([2H])\[2H] |
| Canonical Smiles | CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C |
| InchIKey | KORNTPPJEAJQIU-WDORCQELSA-N |
| Inchl | InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21?,23-/m1/s1/i1D2,5D,11D2 |
| IUPAC | (6aR,9R)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-(1,1,2,3,3-pentadeuterioprop-2-enyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Cabergoline D5 is a medication that is primarily used to treat high levels of prolactin hormone in the body, a condition known as hyperprolactinemia. This medication is a derivative of cabergoline, a dopamine receptor agonist that works by reducing the production of prolactin in the body. Cabergoline D5 is a deuterated form of cabergoline, which means that it contains five deuterium atoms, a form of hydrogen that is heavier than the usual hydrogen atom.
The deuterated form of cabergoline, Cabergoline D5, is used in scientific research to study the pharmacokinetics and metabolism of cabergoline. This is because deuterated compounds are useful tools for studying the metabolic pathways of drugs, as they can be easily detected and quantified using mass spectrometry techniques.
The chemical formula of Cabergoline D5 is C26H37D5N2O2, and its molecular weight is 422.69 g/mol. The medication is available in the form of tablets, which are taken orally. The usual recommended dose of Cabergoline D5 is 0.25 mg twice a week, although the dosage may vary depending on the individual's condition and response to treatment.
Cabergoline D5 may cause side effects such as nausea, dizziness, headache, and fatigue. It may also interact with other medications, so it is important to inform your doctor about any other medications you may be taking. Overall, Cabergoline D5 is an important tool in scientific research and can be an effective treatment option for hyperprolactinemia when used under the guidance of a healthcare professional.
Get an Instant Quote
Related Compounds
Desethylcarbamoyl Cabergoline-d5 |